My Cart

Human CCR4 Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Qty
CC4-H52P3-20ug
$620.00
CC4-H52P3-100ug
$1235.00
CC4-H52P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    CKR4, K5-5, CD194, CMKBR4, ChemR13, CC-CKR-4, HGCN:14099

  • Source

    Human CCR4 Full Length Protein (VLP) (CC4-H52P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Leu 360 (Accession # P51679-1).

    Predicted N-terminus: Met 1

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Purity

    >95% as determined by SEC-HPLC.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SEC-HPLC

    CCR4 SEC-HPLC

    The purity of Human CCR4 Full Length Protein (VLP) (Cat. No. CC4-H52P3) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     CCR4 ELISA

    Immobilized Human CCR4 Full Length Protein (VLP) (Cat. No. CC4-H52P3) at 5 μg/mL (100 μL/well) can bind Human Anti-CCR4 antibody, Human IgG1 with a linear range of 0.01-0.625 μg/mL (QC tested).

    Protocol
  • Identity-DLS

     CCR4 DLS

    The mean peak Radius of VLP is 50-80 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

CCR4 is a chemokine receptor driving Th2 and Treg cell trafficking to skin and lung. It is a clinically validated target in Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia/Lymphoma via the FDA-approved antibody mogamulizumab. CCR4 antagonism is also explored in asthma and atopic dermatitis to reduce Th2 inflammation.

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background